Calcium Hydroxylapatite (CaHA) Fillers Market Size, Share, Growth, and Industry Analysis, By Type (Injectable CaHA Fillers, Dermal Fillers, and Microparticle CaHA Fillers), By Application (Aesthetic Procedures, Dermatology, Plastic Surgery, Anti-aging, Skin Rejuvenation, Non-surgical Facial Treatment), and Regional Insights and Forecast to 2033

•   
•   
  

  Request a Free sample to learn more about this report

    

CALCIUM HYDROXYLAPATITE (CAHA) FILLERS MARKET OVERVIEW

Calcium hydroxylapatite is currently one of the most studied types of dermal fillers worldwide, and its use has been very important in the correction of moderate-to-severe lines and folds irregularities and also a deficit of facial volume. CaHA is a very capable agent in the vast majority of fields of facial soft-tissue augmentation and has a well-known, acceptable safety record. CaHA is a bio ceramic of extraordinarily high biocompatibility, such that when injected, it triggers the regeneration of collagens I and III, elastin, and proteoglycans, and leads to de novo generation of tissue and vasculature. Clinically, the restored skin becomes more hydrated, tauter, brighter, moldable, elastic, wrinkle-free and younger-looking in a broad assortment of anatomies. Unlike other forms of treatment, e.g. PLLA, CaHA induces soft tissue regeneration with the least recruitment of adaptive immune cells and without persistent inflammation.

The increasing need for minimally invasive cosmetic surgical operations spurs the market growth, as more than 14.7 million aesthetic procedures worldwide in 2024 will apply dermal fillers. A major reason why CaHA fillers have become very popular is their ability to supply natural-looking outcomes that could last up to 12-18 months, which is pretty long compared to the regular dermal fillers. Calcium hydroxylapatite has bio-stimulatory effects and is thus highly appealing to clients requiring entire facial rejuvenation since it not only volumizes, but also triggers the production in the body, which increases skin firmness and texture in the long run. The International Society of Aesthetic Plastic Surgery reports that out of the total number of procedures (which stand at 697,455) carried out in 2022 all over the world, about 350,716 of those procedures involved CaHA fillers, with 50.2 percent of all fillers used in the United States of America being carried out on patients aged between the ages of 55 and 69.

COVID-19 IMPACT

Calcium Hydroxylapatite (CaHA) Fillers Industry Had a Negative Effect Due to Healthcare Restrictions and Reduced Cosmetic Procedures during the COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic that was taking over the world also had a considerably negative effect on the calcium hydroxylapatite fillers market, as it dealt a tremendous blow to the aesthetic medicine market. Due to the pandemic, mass quarantine was introduced, medical institutions closed, and enhanced safety standards under which non-urgent care, such as cosmetic treatment, were largely suspended. According to the International Society of Aesthetic Plastic Surgery, CaHA filler administrations dropped 17 per cent in 2020 than in the pre-coronavirus situation. This was most felt during the first half of 2020 because the majority of the cosmetic clinics and med spas had to shut down or work on limited capacity. In December 2020, the COVID-19 impact led to a moderate decline, by -10.3%, in annual revenues at the manufacturer of the Radiesse, Merz Pharma.

LATEST TRENDS

Integration of Hybrid Filler Technologies to Drive Market Growth

New developments in the market of calcium hydroxylapatite fillers have been regarding the introduction of novel hybrid solutions applying CaHA with other types of fillers in an attempt to achieve an optimal outcome of the treatment. Addition of hyaluronic acid (HA) to calcium hydroxylapatite has become an important trend, and certain products, e.g. HarmonyCA, provide immediate volumizing effects of HA with the longer-term collagen-producing properties of CaHA. This combined manner will enable the practitioners to accomplish immediate patient satisfaction as well as long-term, aesthetics-enhancing services, making treatment last longer. The tendency of the diluted and hyper-diluted formulations of CaHA has also been intensifying, as it allows practitioners to create individual treatment options in various facial areas and individual requirements of the patients. Diluted CaHA can also be used to tighten the skin and to rejuvenate the face in a global way without losing the bio-stimulatory effects of the material. This flexibility has not only broadened the usage of CaHA fillers in more conventional volumizing procedures, but also in the use of full facial rejuvenating treatment.

•   
•   
  

  Request a Free sample to learn more about this report

    

CALCIUM HYDROXYLAPATITE (CAHA) FILLERS MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Injectable CaHA Fillers, Dermal Fillers, and Microparticle CaHA Fillers

• Injectable CaHA Fillers: The common usages of injectable CaHA fillers are in soft tissue augmentation and the contouring of the face. They provide long-term results and are rather famous to be used to enhance the face structure, being rather non-invasive.

• Dermal Fillers: Dermal CaHA implants enhance volumizing of the skin and diminish wrinkle lines. They are most familiar in cosmetic dermatology to treat nasolabial folds and marionette lines, among other signs of age-related volume loss.

• Microparticle CaHA Fillers: The CaHA fillers are microparticles that give the skin-deep tissue support and make it produce collagen. They can effectively be used in more specific and permanent structural improvement of aesthetic procedures.

By Application

Based on application, the global market can be categorized into Aesthetic Procedures, Dermatology, Plastic Surgery, Anti-aging, Skin Rejuvenation, Non-surgical Facial Treatment

• Aesthetic Procedures: CaHA fillers have become more common in aesthetic care to create volume and shape areas of the face to provide volumizing and plumping effects that are natural-looking and with little or no downtime.

• Dermatology: CaHA fillers aid in the treatment of volume deficiencies, scars due to acne and skin laxity in dermatology and become a reliable resource in making small adjustments cosmetically without invasive intervention.

• Plastic Surgery: Plastic surgeons incorporate CaHA fillers in surgery aimed at shaping the surgical result better, facial symmetry, and enhancing structural beauty with no implants.

• Anti-aging: Anti-aging products are aimed at minimizing wrinkles and filling in the youthful skin. CaHA fillers help to increase the production of collagen and lead to gradual and long-term rejuvenation.  

• Skin Rejuvenation: CaHA injections also help to rehydrate sallow or aging skin; they boost the skin texture and its elasticity by stimulating fibroblasts and natural tissue regeneration.

• Non-surgical Facial Treatment: The fillers have also been the most preferred in the non-surgical methods of remodeling the jawlines, cheekbones, among other facial shapes, to help them obtain the sculptured facial appearance without necessarily undergoing interventions.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Increasing Demand for Non-Surgical Aesthetic Procedures to Boost the Market

A factor in the Calcium Hydroxylapatite (CaHA) Fillers market growth is that non-surgical cosmetic procedures have shown an exponential rise in demand, and this is the driving force in the calcium hydroxylapatite fillers market. The drive to minimally invasive aesthetics has many factors that influence it globally, and they include shorter recovery duration, affordability as compared to surgical operations, and safer records of these treatments. In 2022, the global market of dermal fillers was $5.5 billion, and it is projected to rise at a 10.5% CAGR to reach up to $14.8 billion in size by 2032, with CaHA fillers contributing to a substantial part of the increase. There has been an enormous change in consumer preferences for procedures that provide only natural-looking outcomes with minimal recovery time. CaHA fillers are the solution to this requirement, as they have the volume-restoring effect and the ability to induce long-term collagen synthesis, allowing the aesthetic effects to improve with time. The increased popularity of social media and beauty awareness among consumers, especially millennials and Gen Z, has led to an unforeseen level of demand for aesthetic procedures used to sustain youthfulness.

Aging Population Demographics and Longevity of CaHA Fillers to Expand the Market

The demographic of an aging population across the world is a prominent motivating factor attributable to the CaHA fillers market. The demographic transformation is accompanied by rising disposable income of the aged population and the growing popularity of cosmetic procedures. CaHA fillers are specifically suited to the needs of this ageing population since they are also well-suited to solving age-based losses of volume. The ability of CaHA fillers to outlast other dermal fillers on a longevity basis offers a major value to the patients. The studies conducted on level II of evidence demonstrate longevity of 30 months plus following the treatment of nasolabial folds, which is significantly more than the 6-12 months of hyaluronic acid fillers. This long-lasting period minimizes the occurrence of maintenance procedures, hence making the CaHA fillers more economical to the patient and building on the overall attraction to the patient market.

Restraining Factor

Potential Adverse Events and Complications Associated with CaHA Fillers to Potentially Impede Market Growth

Even though, directly, CaHA fillers are safe, when they are not used properly, they can lead to serious complications. Injection of calcium hydroxylapatite inter-arterially has the potential to cause serious complications such as soft tissue necrosis, scar formation, blindness, and visual deficiency. These dangerous and light-occurring adverse events need very much specialist training of practitioners and a selective patient population, which may be a barrier to market expansion. Another area of concern is nodules and granulomas formation, but the number of nodules and granulomas is less with CaHA fillers than they are with poly-L-lactic acid (PLLA) fillers. However, risks of the adverse events demand thorough patient scrutiny and skilled injection procedures, which can considerably shrink the ranks of skilled individuals and curtail market growth.

Expanding Applications and Combination Therapies Create Opportunity for the Market

Opportunity

Calcium hydroxylapatite fillers market also holds great opportunities with regards to the finding of new applications, and combination therapies. Combination of CaHA with the other aestheticizing procedures, such as lasers, radiofrequency devices, and other injectable therapies, in effect provides a synergistic effect that improves the overall outcomes of treatment. It is also the trend of multimodal aesthetic procedures that opens space and potential to expand the use of CaHA filler and generate higher revenue per patient.

The body contouring and hand rejuvenation applications are also emerging and pose huge growth opportunities. FDA approval of hand rejuvenation procedures has brought with it new market segments, and off-label use of the procedure currently includes body contouring, such as buttock augmentation, as well as breast enhancement, which brings revenue possibilities. Market applications may be further expanded by the development of special CaHA formulations which target specific anatomical regions.

Regulatory Compliance and Safety Concerns Could Be a Potential Challenge for Consumers

Challenge

The calcium hydroxylapatite fillers market has major regulatory threats, which include safety concerns and clinical evidence profile. High levels of clinical data to prove safety and efficacy through regulatory bodies act as a barrier to entry for new manufacturers and also raise the development cost. The consideration of certification and special training of practitioners towards market development complicates the situation further and can reduce the number of qualified injectors.

In addition, dealing with customer expectations and outcomes optimization is also a constant issue faced by the market. CaHA fillers are semi-permanent and thus, as an option, patient selection has to be thoughtful and injection skills have to be proficient to deliver pleasant outcomes. Unsuccessful cases might create negative publicity and affect the perception of practitioner products in the market, so the education of practitioners and quality management are paramount success factors.

•   
•   
  Request a Free sample to learn more about this report

    

CALCIUM HYDROXYLAPATITE (CAHA) FILLERS MARKET REGIONAL INSIGHTS

• North America

North America is the biggest local market for calcium hydroxylapatite fillers. The United States Calcium Hydroxylapatite (CaHA) Fillers Market is the leader with the largest number of CaHA filler procedures in 2023, and that is expected to be greater than 1.4 million due to established healthcare infrastructure, high disposable income levels, and consumer acceptance rates concerning aesthetic procedures. The region also has advantageous regulatory conditions with many CaHA applications, such as facial wrinkles, facial folds, and hand replenishment, being approved by the FDA. The existence of large market participants such as Merz Pharmaceuticals and other market-leading aesthetic firms has harnessed powerful distribution systems and education programs of practitioners.

• Europe

Europe is about 30 per cent of the total CaHA fillers market, and in 2023, Germany and the UK will have more than 620,000 treatments. The region also enjoys European Union Medical Device Regulation (MDR) approvals that help sellers access the market within and across member nations. The new EU access to decolletage treatment has broadened the horizon of the application and has activated the growth of the market. In Europe, aesthetic medicine acceptance is high, and there is a developed and advanced healthcare system to serve the medical and cosmetic needs of CaHA fillers. Certain nations, such as France, Italy, and Spain, are more prominent in terms of growth. This can be attributed to a developed culture of aesthetic medicine as well as an increasing number of consumers using their money on cosmetic procedures. The availability of such major organizations as Merz Pharma GmbH in Germany has established a good local infrastructure and practitioner back-up systems.  

• Asia

The Asia-Pacific region is about one-fifth of the world market and high in terms of growth potential. The healthcare industry in the region is largely constituted by the fast-growing healthcare infrastructure, flourishing disposable income, and rising acceptance of aesthetic medicine amongst the younger generations. China has taken the domination in the regional market, where there are large investments in the field of aesthetic medicine and the rise of consumer awareness about cosmetic procedures. The Indian market picks up well. Japan and South Korea are mature markets which have developed an aesthetic medicine industry and high-end consumer spending on beauty therapies. The rising population of the middle class in the region and the rising power of social media and beauty ideals are compelling people to undergo aesthetic treatment.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Strategic Partnerships and Product Development

The competitive environment of the calcium hydroxylapatite fillers market is quite concentrated, and several prominent players are performing in this business sphere, innovating their products and expanding to new markets by means of joint enterprises, product development, and distribution systems that cover all parts of the globe. Such companies are dedicated to the improvement of product formulations, the expansion of the application possibilities and the enhancement of patient outcomes, which are achieved through ongoing investments in research and development. Manufacturers on the frontline are spending a lot of money on clinical trials, to prove the safety and effectiveness of their products, and are also coming up with new formulations, which have better injection properties and produce longer-lasting effects. The combination of high-tech synergetic manufacturing processes and quality management systems leads to the maintenance of quality and regulatory conformity of the products in the global markets.

List Of Top Calcium Hydroxylapatite (Caha) Fillers Companies

• Merz Pharma (Germany)
• BioScience GmbH (Germany)
• Sinclair Pharma (UK)
• Prollenium Medical Technologies Inc. (Canada)
• Croma-Pharma GmbH (Austria)
• IMEIK Technology Development Co., Ltd (China)
• Dr. Korman Laboratories (Israel)
• HansBiomed Corp (South Korea)
• ROKIT Healthcare (South Korea)
• BNC Global Esthetics Inc. (South Korea)

KEY INDUSTRY DEVELOPMENT

October 2023: The high international interests in advanced aesthetic treatments were evidenced by the significant market expansion of CG Bio on one hand with its opening of the complete line of fillers (FACETEM) in Indonesia and on the other hand with its exporting contract with HTDK totaling to USD 100 million to increase its CaHA filler products in mainland China.  

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The future market outlooks show a strong rise in the market that will be stimulated by the growth in consumer uptake of aesthetic procedures, the increase in technological advances in product formulation, and expansions in the application of CaHA fillers. Sustained research and development of hybrid products, enhanced injection processes, and its worldwide distribution facilities are likely to pose an advantage to the market. As the industry in aesthetic medicine keeps growing, calcium hydroxylapatite fillers are set to take on a bigger role in the non-invasive facial remodeling and body-shaping procedures.

Do not change the format of this line, only values, CAGR and market name changes with each topic